| 中文名 | 人牛吡啶Apelin-13 |
|---|---|
| 英文名 | [Pyr1]-Apelin-13 |
| 中文别名 |
[Pyr1]-Apelin-13-[Pyr1]-爱帕琳肽-13
3-二甲基尿酸 PYR1]-爱帕琳肽-13醋酸盐 [PYR1]-APELIN 13,ENDOGENOUS APELIN RECTOR (APJ)激动剂 [PYR1]-爱帕琳肽-13 (GLP1)-APELIN-13(人,牛) 人牛吡啶APELIN-13 焦谷氨酸1]-Apelin-13 (S)-2-((S)-1-((S)-2-((S)-1-((6S,9S,12S,15S,18S)-15-((1H-咪唑-4-基)甲基)-1-氨基-18-(4-氨基丁基)-6-((S)-1-((S)-5-胍基-2-((S)-5-氧代吡咯烷-2-甲酰氨基)戊酰基)吡咯烷-2-甲酰氨基)-12-(羟甲基)-1-亚氨基-9-异丁基7,10,13,16,19-五氧代-2,8,11,14,17,20-六氮杂二十二烷-22-酰基)吡咯烷-2-甲酰氨基)-4-(甲硫基)丁酰基)吡咯烷-2-甲酰氨基)-3-苯基丙酸 PYR1] -APELIN-13 三氟乙酸盐 人,牛(GLP1)-APELIN-13肽 人牛吡啶APELIN-13 Solbio/索莱宝 IP1170 |
| 英文别名 |
pQRPRLSHKGPMPF
[PYR1]-APELIN-13 [Pyr1]-Apelin-13,XRPRLSHKGPMPF,[pGlu1]-Apelin-13 3-Dimethyluric acid PYR-G-PRO-G-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE-OH //BP Deltorphin I (GLP1)-APELIN-13, HUMAN, BOVINE GLP-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE [PGLU1]APELIN , HUMAN, BOVINE (PYR1)-APELIN-13 (HUMAN, BOVINE, MOUSE, RAT) {Glp}-RPRLSHKGPMPF [Pyr1]-Apelin 13, endogenous apelin rector (APJ) agonist (Glp1)-Apelin-13 [PE]APELIN-13, HUMAN, BOVINE PYR-G-PRO-G-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE GLP-G-PRO-G-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE GLP-G-PRO-G-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE: PRLSHKGPMPF (Pyr)-Apelin-13 (human, bovine, mouse, rat) acetate salt PYR-G-PRO-G-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE-OH PYR-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE L-Phenylalanine, 5-oxo-L-prolyl-L-ginyl-L-prolyl-L-ginyl-L-leucyl-L-seryl-L-histidyl-L-lysylglycyl-L-prolyl-L-methionyl-L-prolyl Pyr-apelin-13 5-Oxo-L-prolyl-L-ginyl-L-prolyl-L-ginyl-L-leucyl-L-seryl-L-histidyl-L-lysylglycyl-L-prolyl-L-methionyl-L-prolyl-L-phenylalanine pyroglutamyl apelin-13 PGLU-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE PGLU-G-PRO-G-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE [pGlu1]-Apelin-13 PYR-RPRLSHKGPMPF-OH [Pyr1]-Apelin-13 trifluoroacetate salt 5-Oxo-L-prolyl-L-arginyl-L-prolyl-L-arginyl-L-leucyl-L-seryl-L-histidyl-L-lysylglycyl-L-prolyl-L-methionyl-L-prolyl-L-phenylalanine (PYR1)-APELIN-13 (HUMAN, BOVINE) |
| 描述 | [Pyr1]-Apelin-13 是一种高效的,选择性的内源性 apelin 受体激动剂。 |
|---|---|
| 相关类别 | |
| 体外研究 | [pyr1] -apelin-13在lipoPEG颗粒(lipoPEG-PA13)中的包封导致在生理条件下持续和延长的药物释放[1]。 |
| 体内研究 | [Pyr1] -apelin-13纳米载体在压力超负荷诱导的心力衰竭小鼠模型中显示[Pyr1] -apelin-13在预防心脏功能障碍中的可持续长期作用[1]。 [Pyr1] apelin-13(1,5μg)可改善大鼠的运动活动并减轻疼痛症状,腔大小和caspase-3水平。 [Pyr1] apelin-13(1,5μg)显着增加热爪退缩潜伏期。与来自SCI后第2周的SCI动物相比,5μg剂量的[Pyr1] apelin-13也在缩爪阈值中产生显着的减弱[2]。 |
| 参考文献 |
| 密度 | 1.5±0.1 g/cm3 |
|---|---|
| 分子式 | C69H108N22O16S |
| 分子量 | 1533.8 |
| 精确质量 | 1532.80343662 |
| PSA | 613.26000 |
| LogP | -3.42 |
| 折射率 | 1.696 |
| 储存条件 | 保存方法: -15 °C |
|
详细
|
| 文献:Zhang, Yanyan; Maitra, Rangan; Harris, Danni L.; Dhungana, Suraj; Snyder, Rodney; Runyon, Scott P. Bioorganic and Medicinal Chemistry, 2014 , vol. 22, # 11 p. 2992 - 2997 |
| 上游产品 7 | |
|---|---|
| 下游产品 0 | |